Anti-cancer Chinese medicinal powder and preparation method thereof

Abstract

The invention relates to anti-cancer Chinese medicinal powder and a preparation method thereof, belonging to the technical field of medicament. The Chinese medicinal powder comprises the following medicinal materials: venin microcrystalline cellulose clathrate compound, green tea CO2 supercritical extract, gynostemma pentaphylla CO2 supercritical extract, epimedium CO2 supercritical extract, shizandra berry CO2 supercritical extract, lesser galangal rhizome CO2 supercritical extract, ganoderma lucidum fine powder, broken ganoderma spore powder, zedoary fine powder, sculellaria barbata fine powder, radix zanthoxyli fine powder, celandine fine powder, semen coicis fine powder, Chinese date fine powder, isatis root fine powder, prepared rehmannia rhizome fine powder and astragalus mongholicus fine powder, wherein the prepared medicinal powdered preparations are mixed uniformly and encapsulated according to medicament formula. According to weight of a patient body, the Chinese medicinal powder is mixed with warm water 30 minutes before meals, and is taken 3.5 to 4.5 grams per time. The Chinese medicinal powder is forbidden to the patient who is subjected to visceral major surgeries in one month. The Chinese medicinal powder can effectively treat solid tumors and mainly treat lung cancer, and has good curative effect to solid tumor of a digestive system.

Description

technical field [0001] The invention relates to an anticancer traditional Chinese medicine powder and a preparation method thereof, belonging to the technical field of medicine. Background technique [0002] Cancer is a disease that is difficult to cure among contemporary humans. In my country, more than 2.3 million cases occur each year, and the death toll reaches more than 1.7 million. There are many kinds of drugs and adjuvant therapy methods for treating cancer at present, but the effect is not ideal. [0003] The inventor declared "an anticancer traditional Chinese medicine powder and its preparation method" (01123530.6) on July 30, 2001, and obtained authorization (CN1183928C) on January 12, 2005. In the subsequent nearly ten years of clinical treatment practice, a new prescription was developed, and its formula composition, processing technology, and clinical efficacy have made significant progress compared with the original patented drug, and the therapeutic effect ...

AI Technical Summary

Problems solved by technology

There are many drugs and adjuvant treatments for cancer, but the effect is not ideal